Jonathan P Terdiman

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Prevention of postoperative recurrence in Crohn's disease
    Jonathan P Terdiman
    University of California, San Francisco, San Francisco, California 94115, USA
    Clin Gastroenterol Hepatol 6:616-20. 2008
  2. ncbi request reprint Ulcerative colitis patients with dysplastic polyps should be advised to undergo colectomy
    Jonathan P Terdiman
    Center for Colitis and Crohn s Disease, University of California, San Francisco, San Francisco, CA 94115, USA
    Inflamm Bowel Dis 12:916-8. 2006
  3. pmc Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study
    Jonathan P Terdiman
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
    Dig Dis Sci 54:2488-96. 2009
  4. ncbi request reprint 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
    Jonathan P Terdiman
    University of California, San Francisco, San Francisco, California 94143 1623, USA
    Inflamm Bowel Dis 13:367-71. 2007
  5. ncbi request reprint Oncology training for the gastroenterologist: a test-case for subspecialization in gastroenterology?
    Jonathan P Terdiman
    University of California, San Francisco, San Francisco, California 94143, USA
    Gastroenterology 135:1028-31. 2008
  6. ncbi request reprint Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines
    Fernando S Velayos
    Division of Gastroenterology and Colorectal Cancer Prevention Program, University of California, San Francisco, CA, USA
    Am J Gastroenterol 100:1143-9. 2005
  7. ncbi request reprint A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history
    Brindusa Truta
    Department of Medicine, Division of Gastroenterology and the Comprehensive Cancer Center, University of California San Francisco, 2330 Post Street, San Francisco, CA 94115 1623, USA
    Fam Cancer 4:127-33. 2005
  8. ncbi request reprint BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer
    Guoren Deng
    Department of Medicine, Veteran Affairs Medical Center and Cancer Center, University of California San Francisco, California, USA
    Clin Cancer Res 10:191-5. 2004
  9. ncbi request reprint The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer
    Fernando S Velayos
    Division of Gastroenterology and Colorectal Cancer Prevention Center, Department of Medicine, University of California San Francisco, California, USA
    J Gastrointest Surg 9:329-35. 2005
  10. doi request reprint Tumor histology helps to identify Lynch syndrome among colorectal cancer patients
    Brindusa Truta
    Department of Medicine, Gastroenterology Division, University California San Francisco, 2330 Post St, Suite 610, San Francisco, CA 94115, USA
    Fam Cancer 7:267-74. 2008

Detail Information

Publications43

  1. ncbi request reprint Prevention of postoperative recurrence in Crohn's disease
    Jonathan P Terdiman
    University of California, San Francisco, San Francisco, California 94115, USA
    Clin Gastroenterol Hepatol 6:616-20. 2008
  2. ncbi request reprint Ulcerative colitis patients with dysplastic polyps should be advised to undergo colectomy
    Jonathan P Terdiman
    Center for Colitis and Crohn s Disease, University of California, San Francisco, San Francisco, CA 94115, USA
    Inflamm Bowel Dis 12:916-8. 2006
  3. pmc Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study
    Jonathan P Terdiman
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
    Dig Dis Sci 54:2488-96. 2009
    ..Preclinical data suggest that 5-aminosalicylates also may have a chemopreventive effect...
  4. ncbi request reprint 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
    Jonathan P Terdiman
    University of California, San Francisco, San Francisco, California 94143 1623, USA
    Inflamm Bowel Dis 13:367-71. 2007
    ..The objective of this observational study was to determine if an association between 5-ASA therapy and CRC risk exists in IBD patients...
  5. ncbi request reprint Oncology training for the gastroenterologist: a test-case for subspecialization in gastroenterology?
    Jonathan P Terdiman
    University of California, San Francisco, San Francisco, California 94143, USA
    Gastroenterology 135:1028-31. 2008
  6. ncbi request reprint Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines
    Fernando S Velayos
    Division of Gastroenterology and Colorectal Cancer Prevention Program, University of California, San Francisco, CA, USA
    Am J Gastroenterol 100:1143-9. 2005
    ..We sought to determine the rate of MSI in adenomas removed from individuals under 40 yr of age over a 5-yr period in a university general gastroenterology practice...
  7. ncbi request reprint A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history
    Brindusa Truta
    Department of Medicine, Division of Gastroenterology and the Comprehensive Cancer Center, University of California San Francisco, 2330 Post Street, San Francisco, CA 94115 1623, USA
    Fam Cancer 4:127-33. 2005
    ..We studied the phenotype and genotype of adenomatous polyposis in patients without a family history...
  8. ncbi request reprint BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer
    Guoren Deng
    Department of Medicine, Veteran Affairs Medical Center and Cancer Center, University of California San Francisco, California, USA
    Clin Cancer Res 10:191-5. 2004
    ..In this study, we sought to compare the frequencies of BRAF mutations in sporadic colorectal cancer with MSI with those in hereditary nonpolyposis colorectal cancer (HNPCC)...
  9. ncbi request reprint The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer
    Fernando S Velayos
    Division of Gastroenterology and Colorectal Cancer Prevention Center, Department of Medicine, University of California San Francisco, California, USA
    J Gastrointest Surg 9:329-35. 2005
    ..In contrast, more MSI-H metachronous CRCs were associated with patient and tumor characteristics suggestive of underlying hereditary nonpolyposis CRC...
  10. doi request reprint Tumor histology helps to identify Lynch syndrome among colorectal cancer patients
    Brindusa Truta
    Department of Medicine, Gastroenterology Division, University California San Francisco, 2330 Post St, Suite 610, San Francisco, CA 94115, USA
    Fam Cancer 7:267-74. 2008
    ..To determine the value of histology in identifying Lynch syndrome among those patients with early onset of colorectal cancer (CRC)...
  11. ncbi request reprint Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness
    Carolina M Reyes
    Department of Clinical Pharmacy, University of California, San Francisco 94143, USA
    Cancer 95:1848-56. 2002
    ..Molecular testing for hereditary nonpolyposis colorectal carcinoma (HNPCC) is becoming standard care and it is cost-effective compared with no genetic testing. However, the best strategy for detection of HNPCC gene carriers is unknown...
  12. doi request reprint Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis
    Brindusa Truta
    99 Lupine Ave, 503, San Francisco, CA, 94118, USA
    Dig Dis Sci 59:135-45. 2014
    ..One of the causes of pouch failure after ileal pouch anal anastomosis (IPAA) for ulcerative colitis (UC) is the development of de novo Crohn's disease (CD). Our aim was to clearly define factors associated with post-IPAA CD...
  13. ncbi request reprint Colorectal cancer screening: clinical applications
    Judith M E Walsh
    Division of General Internal Medicine, Department of Medicine, Women s Health Clinical Research Center, University of California San Francisco, Campus Box 1793, 1635 Divisadero Suite 600, San Francisco, CA 94115, USA
    JAMA 289:1297-302. 2003
    ..Many potential barriers to colorectal cancer screening exist for the patient and the physician. Strategies to increase compliance for colorectal cancer screening are proposed...
  14. pmc Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach
    Amandeep K Shergill
    Veterans Affairs Medical Center, Division of Gastroenterology, University of California, San Francisco 94143, United States
    World J Gastroenterol 14:2670-7. 2008
    ....
  15. pmc Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events
    Jennifer Y Wang
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    World J Gastroenterol 15:927-35. 2009
    ..To compare thromboembolism rates between patients with ulcerative colitis undergoing a colorectal operation and other patients undergoing colorectal operations...
  16. ncbi request reprint Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma
    Brindusa Truta
    University California San Francisco, Department of Medicine, Comprehensive Cancer Center, San Francisco, California, USA
    Fam Cancer 2:95-9. 2003
    ..Additionally, thyroid cancer in our patients occurred in the setting of classic FAP phenotype. Germline mutations were located predominantly outside the APC mutation cluster region...
  17. ncbi request reprint Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies
    Fernando S Velayos
    Division of Gastroenterology and UCSF Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94143, USA
    Am J Gastroenterol 100:1345-53. 2005
    ..We performed a systematic review with metaanalysis of observational studies evaluating the association between 5-ASA use and colorectal cancer (CRC) or dysplasia among patients with ulcerative colitis...
  18. ncbi request reprint Chromosomal instability in microsatellite-unstable and stable colon cancer
    Karolin Trautmann
    Comprehensive Cancer Center, Department of Medicine, University of California San Francisco, San Francisco, California 94143 0808, USA
    Clin Cancer Res 12:6379-85. 2006
    ....
  19. doi request reprint Durability of infliximab dose intensification in Crohn's disease
    Kirk K Lin
    Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
    Dig Dis Sci 57:1013-9. 2012
    ..Dose intensification is a common approach to treat Crohn's disease (CD) patients who lose response to infliximab maintenance therapy. Few studies have reported upon its long-term efficacy or predictors of response...
  20. ncbi request reprint Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer
    Kshama R Mehta
    Comprehensive Cancer Center, Department of Surgery, University of California San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA
    Clin Cancer Res 11:1791-7. 2005
    ..Identification of molecular markers that predict patients at highest risk for recurrence may help to target further therapy...
  21. ncbi request reprint Association of large serrated polyps with synchronous advanced colorectal neoplasia
    Dan Li
    Department of Medicine, University of California, San Francisco, 94115, USA
    Am J Gastroenterol 104:695-702. 2009
    ..Accumulating evidence suggests that they may have different malignancy potentials. This study sought to determine the association between the presence of large serrated colorectal polyps and synchronous advanced colorectal neoplasia...
  22. ncbi request reprint Colorectal cancer screening: scientific review
    Judith M E Walsh
    Division of General Internal Medicine, Department of Medicine, Women s Health Clinical Research Center, University of California San Francisco, Campus Box 1793, 1635 Divisadero Suite 600, San Francisco, CA 94115, USA
    JAMA 289:1288-96. 2003
    ..Clinicians are challenged to ensure that eligible patients undergo colorectal cancer screening and to guide patients in choosing what tests to receive...
  23. ncbi request reprint Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis
    Christian Mathy
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco 94115, USA
    Inflamm Bowel Dis 9:351-5. 2003
    ..The risk of neoplasia associated with the microscopic extent of colitis is unknown. The aim of this study was to describe the gross and microscopic extent of colitis in patients with UC-related dysplasia/CRC...
  24. pmc Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome
    Shilpa Grover
    Division of Gastroenterology, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    J Clin Oncol 27:3981-6. 2009
    ..This study examines colorectal cancer (CRC) risk perception in individuals tested for MMR mutations and identifies the factors associated with an appropriate interpretation of their cancer risk...
  25. pmc Promoting use of colorectal cancer screening tests. Can we change physician behavior?
    Judith M E Walsh
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, California, USA
    J Gen Intern Med 20:1097-101. 2005
    ..Colorectal cancer (CRC) screening is underutilized despite evidence that screening reduces mortality...
  26. ncbi request reprint Endoscopic management of familial colonic neoplasia
    Yuki Young
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, 94115, USA
    Gastrointest Endosc Clin N Am 15:549-80, ix-x. 2005
    ..Genetic testing is commercially available for most of the hereditary colorectal cancer syndromes and can greatly facilitate the management of patients if properly undertaken...
  27. ncbi request reprint Infliximab and semen quality in men with inflammatory bowel disease
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California 94115, USA
    Inflamm Bowel Dis 11:395-9. 2005
    ..There is no available data on the effects of infliximab on semen quality. The aim of this study was to determine whether changes in semen quality occurred in men receiving infliximab...
  28. ncbi request reprint Colorectal cancer at a young age
    Jonathan P Terdiman
    Division of Gastroenterology, University of California, San Francisco, CA 94115, USA
    Gastroenterology 128:1067-76. 2005
  29. pmc Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan natives in the Indian Health Service
    Lukejohn W Day
    Division of Gastroenterology, San Francisco General Hospital 3D, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    Dig Dis Sci 56:2104-13. 2011
    ..Studies on colorectal cancer (CRC) screening and incidence among American Indian/Alaska Natives (AI/AN) are few...
  30. ncbi request reprint Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer
    Brian A Allen
    University of California, San Francisco, 1600 Divisadero Street Box 1623, San Francisco, CA 94143, USA
    Best Pract Res Clin Gastroenterol 17:237-58. 2003
    ....
  31. ncbi request reprint High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer
    Jonathan P Terdiman
    Cancer Center, University of California San Francisco, San Francisco, CA, USA
    Cancer Genet Cytogenet 136:129-37. 2002
    ..SMAD2 was retained in four tumors having loss of SMAD4 and DCC. Loss of SMAD4 alone was seen in one tumor. The present data indicate that the loss of SMAD4 and DCC occurs in the majority of colitis-related cancers...
  32. doi request reprint Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis
    Stephen P Nguyen
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    Clin Gastroenterol Hepatol 7:676-81.e1-3. 2009
    ..Studies have reported higher rates of advanced colorectal neoplasia in men than in women. We performed a meta-analysis to provide a quantitative pooled risk estimate of the association between gender and advanced colorectal neoplasia...
  33. ncbi request reprint Evidence-based analysis: postoperative gastric bleeding: etiology and prevention
    Jade S Hiramoto
    Department of Surgery, University of California, 533 Parnassus Ave Room U 372, San Francisco, CA 94143 7088, USA
    Surg Oncol 12:9-19. 2003
    ..Intravenous proton pump inhibitors may be the drugs of choice for stress ulcer prophylaxis (SUP) in high-risk patients...
  34. ncbi request reprint Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry
    Jonathan P Terdiman
    Department of Medicine, University of California, San Francisco 94143, USA
    Gastroenterology 122:940-7. 2002
    ..We sought to compare rates of genetically defined HNPCC among individuals with early onset CRC drawn from a high-risk clinic and a population-based cancer registry...
  35. ncbi request reprint Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study
    Fernando S Velayos
    Division of Gastroenterology, University of California San Francisco, 94143, USA
    Clin Gastroenterol Hepatol 2:485-90. 2004
    ..The aim of this study was to identify risk factors for severe lower gastrointestinal bleeding and for significant adverse outcomes...
  36. pmc Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X
    Noralane M Lindor
    Department of Medical Genetics, Mayo Clinic, Rochester, Minn, USA
    JAMA 293:1979-85. 2005
    ..Cancer incidence in AC-I families with MMR gene mutations is reported to be very high, but cancer incidence for individuals in AC-I families with no evidence of an MMR defect is unknown...
  37. ncbi request reprint The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis
    Daniela E Aust
    Pathologisches Institut der Ludwig Maximilians Universität, Munchen, Germany
    Cancer 94:1421-7. 2002
    ..To elucidate the role of the APC-/beta-catenin pathway in UC-related carcinogenesis, the authors identified APC and beta-catenin mutations in a set of UC-related and sporadic colorectal carcinomas...
  38. ncbi request reprint It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population
    Jonathan P Terdiman
    Gastroenterology 129:741-4. 2005
  39. ncbi request reprint Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer
    Guoren Deng
    Gastrointestinal Research Laboratory, Veteran Affairs Medical Center and Department of Medicine, University of California San Francisco, 94121, USA
    Int J Cancer 118:2999-3005. 2006
    ....
  40. ncbi request reprint Colorectal Cancer Screening Clinical Practice Guidelines
    Bernard Levin
    J Natl Compr Canc Netw 4:384-420. 2006
  41. pmc Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
    Asad Umar
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 96:261-8. 2004
    ....
  42. ncbi request reprint High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization
    Kentaro Nakao
    Second Department of Surgery, Showa University School of Medicine, Tokyo, Japan
    Carcinogenesis 25:1345-57. 2004
    ..Array-based CGH was also able to identify DNA copy number changes in MSI-H tumors...
  43. ncbi request reprint Aspirin curbs colon polyps. But for many, bleeding risks may offset benefits
    Jonathan P Terdiman
    Health News 9:1-2. 2003